USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Operating Cash Flow
Cash generated by the company's core business operations during the period.
USANA Health Sciences, Inc.NYSE: USNA
Operating Cash Flow · Q1 FY2026 · quarter ended Apr 2026
Operating cash flow declines year over year
Q1 FY2026 operating cash flow of $9.76M fell 37.0% year over year, ahead of the -71.7% change in trailing-twelve-month operating cash flow. Over 3 fiscal years it compounded at -40.1% a year.
Context
- Operating cash flow amounted to 2.4% of revenue in FY2025, down 4.7 pp from a year earlier.
- Operating cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -37.0% holds above the trailing-twelve-month pace of -71.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 22.35M USD
- Year-over-year change
- -63.4%
- 4-year CAGR
- -34.5%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 22.35M | -63.4% |
| FY2024 | 2024-12-28 | 60.99M | -13.7% |
| FY2023 | 2023-12-31 | 70.64M | -32.0% |
| FY2022 | 2022-12-31 | 103.9M | -14.3% |
| FY2021 | 2021-12-31 | 121.23M | — |
Operating Cash Flow vs competitors
How USNA compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -71.7% is the 7th highest of 8, against a peer median of +31.3%.
- Operating cash flow amounts to 1.8% of revenue for USNA, versus a peer median of 4.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2025 | CN¥775.15M CNY | +31.3% | +69.4% | 3.2% | |
| LTM Mar 2026 | R$115.92M BRL | +160.3% | -12.1% | 21.2% | |
| LTM Apr 2026 | $72.24M USD | -51.4% | +157.1% | 4.0% | |
| LTM Apr 2026 | $16.63M USD | -71.7% | -40.1% | 1.8% | |
| LTM Mar 2026 | $15.46M USD | +37.2% | +40.0% | 6.7% | |
| LTM Apr 2026 | $10.43M USD | +38.3% | +27.5% | 5.5% | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | $8.66M USD | -80.0% | -30.5% | 0.7% |
| LTM Mar 2026 | $1.1M USD | -51.4% | -56.1% | 0.3% | |
| Peer median (excluding USNA) | — | +31.3% | +27.5% | 4.0% | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 116.51M | 69.35M | 63.79M | 42.06M | 10.76M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 32.56M |
| Deferred Income Tax | (2.97M) | (7.18M) | (2.75M) | (6.74M) | (7.13M) |
| Stock-Based Compensation | 14.3M | 13.49M | 14.6M | 14.56M | 13.83M |
| Change in Working Capital | (28.86M) | 771K | (28M) | (13M) | (43.08M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | (10.5M) | 15.8M | 2.35M | (2.12M) | (34.69M) |
| Accounts Payables | (4.57M) | (2.66M) | (428K) | (1.27M) | 5.2M |
| Other Working Capital | (13.79M) | (12.37M) | (29.92M) | (9.62M) | (13.6M) |
| Other Non-Cash Items | 61K | 6.07M | 2.61M | 1.89M | 15.41M |
| Operating Cash Flow | 121.23M | 103.9M | 70.64M | 60.99M | 22.35M |
| Capital Expenditures | (12.76M) | (10.4M) | (14.49M) | (10.07M) | (13.82M) |
| Acquisitions (Net) | (1.94M) | (6.53M) | 0 | (203.34M) | 0 |
| Purchases of Investments | (1.56M) | 0 | (1.27M) | (870K) | 0 |
| Sales of Investments | 1.94M | 4.56M | 3.78M | 1.13M | 0 |
| Other Investing Activities | 131K | 7K | 15K | 64K | 3.7M |
| Investing Cash Flow | (14.19M) | (12.37M) | (11.98M) | (213.09M) | (10.13M) |
| Debt Repayment | 0 | 0 | 792K | 22.22M | (9M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (177.84M) | (25.38M) | (11.6M) | (9.44M) | (27.51M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.58M) | (4.71M) | (3.43M) | (3.22M) | (4.1M) |
| Financing Cash Flow | (181.41M) | (30.09M) | (14.24M) | 9.55M | (40.6M) |
| Effect of Forex Changes | 2.09M | (13.78M) | (2.5M) | (6.19M) | 5.11M |
| Net Change in Cash | (72.28M) | 47.67M | 41.93M | (148.74M) | (23.27M) |
| Free Cash Flow | 108.46M | 93.5M | 56.15M | 50.92M | 8.53M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.